Postoperative analgesia with rofecoxib. How effective is the preoperative application of a 25 mg dose?;Perioperative schmerztherapie mit rofecoxib: Wie wirksam ist die präoperative gabe einer 25-mg-dosis bei muskuloskelettalen operationen?

Schmerz

Volumn 18, Issue 4, 2004, Pages 278-285

  Steffen, P ^a   Krell, M ^b   Seeling, W ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b Oberschwaben Klinik GmbH Ravensburg

Author keywords

COX 2 inhibitor; Patient controlled analgesia (PCA); Postoperative analgesia; Rofetoxib; Trauma surgery

Indexed keywords

ENFLURANE; FENTANYL; PIRITRAMIDE; PLACEBO; PROPOFOL; ROFECOXIB; SEVOFLURANE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; PATIENT CONTROLLED ANALGESIA; POSTOPERATIVE ANALGESIA; POSTOPERATIVE PAIN; PREOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SIDE EFFECT; TRAUMATOLOGY;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LACTONES; MALE; MIDDLE AGED; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; PERIOPERATIVE CARE; SULFONES;

EID: 4344597721     PISSN: 0932433X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Amrein PC, Ellman LHWH (1981) Aspirin-induced prolongation of bleeding time and perioperative blood loss. J Am Med Assoc 245:1825-1828
2. Barden J, Edwards JE, McQuay HJ, Moore RA (2002) Single-dose rofecoxib for acute postoperative pain in adults: a quantitative systematic review. BMC Anesthesiol 2:4-18
3. Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, Day R, Ferraz MB, Hawkey CJ, Hochberg MC, Kvien TK, Schnitzer TJ (2000) Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. New Engl J Med 23:1520-1528
4. Chang DJ, Desjardins PJ, Chen E, Polis AB, Mcavoy M, Mockoviak SH, Geba GP (2002) Comparison of the analgesic efficacy of rofecoxib and enteric-coated diclofenac sodium in the treatment of postoperative dental pain: a randomized, placebo-controlled clinical trial. Clin Ther 24(4):490-503
5. Chang DJ, Fricke JR, Bird SR, Bohidar NR, Dobbins TW, Geba GP (2001) Rofecoxib versus codeine/acetaminophen in postoperative dental pain: a double-blind, randomized, placebo- and active comparator-controlled clinical trial. Clin Ther 23:1446-1455
6. Day R, Morrison B, Luza A, Castaneda O, Strusberg A, Nahir M, Helgetveit KB, Kress B, Daniels B, Bolognese J, Krupa D, Seidenberg B, Ehrich E (2000) A randomized trial of the efficacy and tolerability of the cox-2 inhibitor rofecoxib vs. ibuprofen in patients with osteoarthritis. Arch Intern Med 160:1781-1787
7. Ehrich EW, Dallob A, De Lepeleire I, Van Hecken A, Riendeau D, Yuan W, Porras A, Wittreich J, Seibold JR, De Schepper P, Mehlisch DR, Gertz BJ (1999) Characterization of rofecoxib as a cyclooxyygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model. Clin Pharmacol Ther 65:336-347
8. Fauno P, Petersen KD, Husted SE (1993) Increased blood loss after preoperative NSAID. Acta Orthopaed Scand 64(5):522-524
9. Geisslinger G, Peskar BA, Pallapies D, Sittl R, Levy M, Brune K (1996) The effects on platelet aggregation and prostanoid biosynthesis of two parenteral analgesics: ketorolac tromethamine and dipyrone. Thromb Haemost 76(4):592-597
10. Hawkey CJ (1999) COX-2 inhibitors. Lancet 353:307-314
11. Heinzl S (2000) Rofecoxib. Zielgerichteter COX-2-Hemmer zur Behandlung der Arthrose in Deutschland zugelassen. Arzneimitteltherapie 47 [suppl]:1-4
12. Joshi W, Connelly NR, Reuben SS, Wolkenhaar M, Thakkar N (2003) An evaluation of the safety and efficacy of administering rofecoxib for postoperative pain management. Anesth Analg 97(1):35-38
13. Lawrence C, Sakuntabhai A, Tiling-Grosse S (1994) Effect of aspirin and nonsteroidal antiinflammatory drug therapy on bleeding complications in dermatologic surgical patients. J Am Acad Dermatol 31(6):988-992
14. Leese PT, Hubbard RC, Karim A (2000) Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: a randomized, controlled trial. J Clin Pharmacol
15. Marret E, Flahault A, Samama CM, Bonnet F (2003) Effects of postoperative, nonsteroidal, antiinflammatory drugs on bleeding risk after tonsillectomy: meta-analysis of randomized, controlled trials. Anesthesiology 98(6):1497-1502
16. Morrison BW, Christensen S, Yuan W, Brown J, Amlani S, Seidenberg B (1999) Analgesic efficacy of the cyclooxygenase-2-specific inibitor rofecoxib in post-dental surgery pain: a randomized, controlled trial. Clin Ther 21:943-953
17. Morrison BW, Fricke J, Brown J, Yuan W, Kotey P, Mehlisch D (2000) The optimal analgesic dose of rofecoxib: overwiew of six randomized controlled trials. JADA 131:1729-1737
18. Pallapies D, Peskar BA, Brune K, Geisslinger G (1994) Effects on platelet functions and pharmacokinetics of azapropazone and ketorolac tromethamine given as single parenteral doses. Br J Clin Pharmacol 37:335-339
19. Pickering AE, Bridge HS, Nolan J, Stoddart PA (2002) Double-blind, placebo-controlled analgesic study of ibuprofen or rofecoxib in combination with paracetamol for tonsillectomy in children. Br J Anaesth 88:72-77
20. Ray WA, Stein CM, Daugherty JR, Hall K, Arbogast PG, Griffin MR (2002) COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease. Lancet 360(9339):1071-1073
21. Reicin A, Brown J, Jove M, deAndrade JR, Bourne M, Krupa D, Walters D, Seidenberg B (2001) Efficacy of single-dose and multidose rofecoxib in the treatment of postorthopedic surgery pain. Am J Orthop 30:40-48
22. Reuben SS, Bhoptkar S, Maciolek H, Joshi W, Sklar D, Sklar J (2002) The preemptive analgesic effect of rofecoxib after ambulatory arthroscopic knee surgery. Anesth Analg 94:55-59
23. Reuben SS, Connelly NR (2000) Postoperative analgesic effects of celecoxib and rofecoxib after spinal fusion surgery. Anesth Analg 91:1221-1225
24. Saag K, van der Heijde D, Fisher C, Smara A, De Tora L, Bolognese J, Sperling R, Daniels B (2000) Rofecoxib, a new cyclooxygenase 2 inhibitor, shows sustained efficacy, comparable with other nonsteroidal anti-inflammatory drugs. Arch Fam Med 9:1124-1134
25. Schafer AI (1999) Effects of nonsteroidal anti-inflammatory therapy on platelets. Am J Med 106:255-355
26. Shen Q, Sinatra R, Luther M, Halaszynski T (2001) Preoperative rofecoxib 25 mg and 50 mg: effects on postsurgical morphin consumption and effort dependent pain. Anesthesiology 95:A961 (abstr)
27. Steffen P, Drück A, Krinn E, Möller A, Georgieff M, Seeling W (1996) Untersuchungen zum differenzierten Einsatz von Nichtopioiden zur postoperativen Analgesie II: Quantifizierung des analgetischen Effektes der Kombination von Metamizol plus Diclofenac mittels der patientenkontrollierten Analgesie. Anesthesiol Intensivmed Notfallmed Schmerzther 31:216-221
28. Steffen P, Krinn E, Möller A, Seeling W, Rockemann M (2002) Metamizol and diclofenac profoundly reduce opioid consumption after minor trauma surgery. Acute Pain 4:71-75
29. Steffen P, Opderbeck S, Seeling W (1993) Reduktion des postoperativen Opioidbedarfs durch die perioperative Gabe von Naproxen. Schmerz 7:167-173
30. Steffen P, Schuhmacher I, Weichel T, Georgieff M, Seeling W (1996) Untersuchungen zum differenzierten Einsatz von Nichtopioiden zur postoperativen Analgesie I: Quantifizierung des analgetischen Effektes von Metamizol mittels der patientenkontrollierten Analgesie. Anesthesiol Intensivmed Notfallmed Schmerzther 31:143-147
31. Steffen P, Seeling W, Reiser A, Rockemann M, Georgieff M (1997) Untersuchungen zum differenzierten Einsatz von Nichtopioiden zur postoperativen Analgesie III: Analgetischer Effekt einer perioperativen Gabe von Metamizol puls Diclofenac nach Spinalanästhesien. Anesthesiol Intensivmed Notfallmed Schmerzther 32:496-501
32. Steffen P, Wiedemann S, Georgieff M, Hähnel J, Treiber H, Seeling W (1994) Kombinierte intravenöse Gabe von Diclofenac und Azapropazon zur postoperativen Analgesie. Schmerz 8:235-242
33. Turan A, Emet S, Karamanlioglu B, Memis D, Turan N, Pamukcu Z (2002) Analgesic effects of rofecoxib in ear-nose-throat surgery. Anesth Analg 9S(S9:1308-1311